CD117, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG

Search, find, compare suppliers for anti-CD117, Human antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD117, Human
CloneREA787
Host SpeciesRecombinant Human
Reactive Specieshuman
IsotypeIgG1
FormatAPC-Vio 770 conjugate
Size30 tests in 60 µL
Concentration1:50
ApplicationsFlow cytometry
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionCD117 Antibody, anti-human, APC-Vio® 770, REAfinity™. Clone REA787 recognizes the human CD117 antigen, also known as c-kit or SCF receptor, which is a 145 kDa receptor tyrosine kinase that is involved in stem cell signaling, activation, and proliferation. The CD117 antigen is expressed on about 1-3% of mononuclear cells from peripheral blood mononuclear cells (PBMCs) or cord blood and on up to 10% of bone marrow cells. CD117 is further expressed on basophils, myeloid dendritic cells, TCRα/β+ T cells, CD19+ B cells, and CD56+ NK cells, as well as on mast cells, melanocytes, and acute myeloid leukemia (AML) blasts. Clone REA787 recognizes a different epitope than clone AC126 and may interfere with SCF-binding. It is therefore not recommended for indirect cell isolation, but is optimal for flow cytometric analysis of cells separated with the CD117 MicroBead Kit, human. | Additional information: Clone REA787 displays negligible binding to Fc receptors.
Immunogenn/a
Other Namesc-kit, PBT, SCFR, KIT
Gene, Accession #Gene ID: 3815
Catalog #130-111-673
Price$146
Order / More InfoCD117, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Product Specific ReferencesBuhring, H. J. et al. (1991) The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hematopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic cells. Leukemia 5: 854-860. | Kubo, H. et al. (2008) Increased cardiac myocyte progenitors in failing human hearts. Circulation 118: 649-657. | Berglund, E. et al. (2013) Evidence for Ca2+-regulated ATP release in gastrointestinal stromal tumors. Exp. Cell Res. 319 (8): 1229-1238.
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197

macs@miltenyibiotec.de

https://www.miltenyibiotec.com

Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.